PLX Annual CAPEX
$1.15 M
+$521.00 K+82.96%
31 December 2023
Summary:
As of January 20, 2025, PLX annual capital expenditures is $1.15 million, with the most recent change of +$521.00 thousand (+82.96%) on December 31, 2023. During the last 3 years, it has risen by +$494.00 thousand (+75.42%). PLX annual CAPEX is now -85.37% below its all-time high of $7.86 million, reached on December 31, 2010.PLX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX Quarterly CAPEX
$87.00 K
-$85.00 K-49.42%
30 September 2024
Summary:
As of January 20, 2025, PLX quarterly capital expenditures is $87.00 thousand, with the most recent change of -$85.00 thousand (-49.42%) on September 30, 2024. Over the past year, it has dropped by -$360.00 thousand (-80.54%). PLX quarterly CAPEX is now -97.06% below its all-time high of $2.96 million, reached on March 31, 2010.PLX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX TTM CAPEX
$1.11 M
-$360.00 K-24.54%
30 September 2024
Summary:
As of January 20, 2025, PLX TTM capital expenditures is $1.11 million, with the most recent change of -$360.00 thousand (-24.54%) on September 30, 2024. Over the past year, it has dropped by -$5000.00 (-0.45%). PLX TTM CAPEX is now -85.91% below its all-time high of $7.86 million, reached on December 31, 2010.PLX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +83.0% | -80.5% | -0.5% |
| 3 y3 years | +75.4% | -80.5% | -0.5% |
| 5 y5 years | +67.5% | -80.5% | -0.5% |
PLX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.3% | +83.0% | -85.5% | +50.0% | -26.1% | +76.3% |
| 5 y | 5-year | -21.3% | +83.3% | -85.5% | +210.7% | -26.1% | +171.3% |
| alltime | all time | -85.4% | +3821.5% | -97.1% | +210.3% | -85.9% |
Protalix BioTherapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $87.00 K(-49.4%) | $1.11 M(-24.5%) |
| June 2024 | - | $172.00 K(-71.2%) | $1.47 M(-2.1%) |
| Mar 2024 | - | $598.00 K(+139.2%) | $1.50 M(+30.5%) |
| Dec 2023 | $1.15 M(+83.0%) | $250.00 K(-44.1%) | $1.15 M(+3.3%) |
| Sept 2023 | - | $447.00 K(+119.1%) | $1.11 M(+53.8%) |
| June 2023 | - | $204.00 K(-17.7%) | $723.00 K(+11.7%) |
| Mar 2023 | - | $248.00 K(+16.4%) | $647.00 K(+3.0%) |
| Dec 2022 | $628.00 K(-57.0%) | $213.00 K(+267.2%) | $628.00 K(-27.2%) |
| Sept 2022 | - | $58.00 K(-54.7%) | $863.00 K(-24.9%) |
| June 2022 | - | $128.00 K(-44.1%) | $1.15 M(-11.8%) |
| Mar 2022 | - | $229.00 K(-48.9%) | $1.30 M(-10.8%) |
| Dec 2021 | $1.46 M(+122.7%) | $448.00 K(+30.2%) | $1.46 M(+13.5%) |
| Sept 2021 | - | $344.00 K(+22.4%) | $1.29 M(+23.2%) |
| June 2021 | - | $281.00 K(-27.2%) | $1.04 M(+7.1%) |
| Mar 2021 | - | $386.00 K(+40.4%) | $975.00 K(+48.9%) |
| Dec 2020 | $655.00 K(+4.5%) | $275.00 K(+169.6%) | $655.00 K(+60.5%) |
| Sept 2020 | - | $102.00 K(-51.9%) | $408.00 K(-41.5%) |
| June 2020 | - | $212.00 K(+221.2%) | $698.00 K(+33.5%) |
| Mar 2020 | - | $66.00 K(+135.7%) | $523.00 K(-16.6%) |
| Dec 2019 | $627.00 K(-8.6%) | $28.00 K(-92.9%) | $627.00 K(-20.3%) |
| Sept 2019 | - | $392.00 K(+959.5%) | $787.00 K(+57.7%) |
| June 2019 | - | $37.00 K(-78.2%) | $499.00 K(-17.8%) |
| Mar 2019 | - | $170.00 K(-9.6%) | $607.00 K(-11.5%) |
| Dec 2018 | $686.00 K(-29.4%) | $188.00 K(+80.8%) | $686.00 K(-12.9%) |
| Sept 2018 | - | $104.00 K(-28.3%) | $788.00 K(-4.1%) |
| June 2018 | - | $145.00 K(-41.8%) | $822.00 K(-17.8%) |
| Mar 2018 | - | $249.00 K(-14.1%) | $1.00 M(+3.0%) |
| Dec 2017 | $971.00 K(+14.4%) | $290.00 K(+110.1%) | $971.00 K(+21.7%) |
| Sept 2017 | - | $138.00 K(-57.3%) | $798.00 K(-2.3%) |
| June 2017 | - | $323.00 K(+46.8%) | $817.00 K(-0.1%) |
| Mar 2017 | - | $220.00 K(+88.0%) | $818.00 K(-3.7%) |
| Dec 2016 | $849.00 K(+83.0%) | $117.00 K(-25.5%) | $849.00 K(+15.4%) |
| Sept 2016 | - | $157.00 K(-51.5%) | $736.00 K(+4.1%) |
| June 2016 | - | $324.00 K(+29.1%) | $707.00 K(+14.8%) |
| Mar 2016 | - | $251.00 K(+6175.0%) | $616.00 K(+32.8%) |
| Dec 2015 | $464.00 K(-40.9%) | $4000.00(-96.9%) | $464.00 K(-26.1%) |
| Sept 2015 | - | $128.00 K(-45.1%) | $628.00 K(-15.8%) |
| June 2015 | - | $233.00 K(+135.4%) | $746.00 K(+20.1%) |
| Mar 2015 | - | $99.00 K(-41.1%) | $621.00 K(-20.9%) |
| Dec 2014 | $785.00 K | $168.00 K(-31.7%) | $785.00 K(-6.4%) |
| Sept 2014 | - | $246.00 K(+127.8%) | $839.00 K(-8.8%) |
| June 2014 | - | $108.00 K(-58.9%) | $920.00 K(-39.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $263.00 K(+18.5%) | $1.51 M(-20.1%) |
| Dec 2013 | $1.89 M(-8.6%) | $222.00 K(-32.1%) | $1.89 M(-1.5%) |
| Sept 2013 | - | $327.00 K(-53.2%) | $1.92 M(-18.8%) |
| June 2013 | - | $699.00 K(+8.9%) | $2.36 M(+24.3%) |
| Mar 2013 | - | $642.00 K(+155.8%) | $1.90 M(-8.1%) |
| Dec 2012 | $2.07 M(-63.8%) | $251.00 K(-67.4%) | $2.07 M(-18.0%) |
| Sept 2012 | - | $770.00 K(+224.9%) | $2.52 M(-7.9%) |
| June 2012 | - | $237.00 K(-70.7%) | $2.74 M(-30.0%) |
| Mar 2012 | - | $810.00 K(+15.1%) | $3.91 M(-31.4%) |
| Dec 2011 | $5.71 M(-27.4%) | $704.00 K(-28.5%) | $5.71 M(-5.5%) |
| Sept 2011 | - | $985.00 K(-30.2%) | $6.04 M(-5.6%) |
| June 2011 | - | $1.41 M(-45.8%) | $6.40 M(-14.7%) |
| Mar 2011 | - | $2.60 M(+150.6%) | $7.50 M(-4.5%) |
| Dec 2010 | $7.86 M(+26.8%) | $1.04 M(-22.6%) | $7.86 M(+6.7%) |
| Sept 2010 | - | $1.34 M(-46.5%) | $7.36 M(-1.1%) |
| June 2010 | - | $2.51 M(-15.2%) | $7.44 M(-5.2%) |
| Mar 2010 | - | $2.96 M(+441.3%) | $7.85 M(+26.7%) |
| Dec 2009 | $6.20 M(+83.8%) | $547.00 K(-61.5%) | $6.20 M(-2.8%) |
| Sept 2009 | - | $1.42 M(-51.3%) | $6.38 M(+12.0%) |
| June 2009 | - | $2.92 M(+123.8%) | $5.69 M(+47.5%) |
| Mar 2009 | - | $1.30 M(+79.3%) | $3.86 M(+14.5%) |
| Dec 2008 | $3.37 M(+44.4%) | $728.00 K(-1.5%) | $3.37 M(-13.7%) |
| Sept 2008 | - | $739.00 K(-32.0%) | $3.91 M(+13.9%) |
| June 2008 | - | $1.09 M(+33.0%) | $3.43 M(+30.1%) |
| Mar 2008 | - | $817.00 K(-35.3%) | $2.64 M(+12.9%) |
| Dec 2007 | $2.33 M(+177.3%) | $1.26 M(+380.2%) | $2.33 M(+83.1%) |
| Sept 2007 | - | $263.00 K(-10.2%) | $1.27 M(+4.4%) |
| June 2007 | - | $293.00 K(-43.2%) | $1.22 M(+3.9%) |
| Mar 2007 | - | $516.00 K(+154.2%) | $1.18 M(+39.5%) |
| Dec 2006 | $842.00 K(-0.2%) | $203.00 K(-2.9%) | $842.00 K(+31.8%) |
| Sept 2006 | - | $209.00 K(-15.4%) | $639.00 K(+48.6%) |
| June 2006 | - | $247.00 K(+35.0%) | $430.00 K(+135.0%) |
| Mar 2006 | - | $183.00 K(-331.9%) | $183.00 K(>+9900.0%) |
| Dec 2005 | $844.00 K(-34.6%) | - | - |
| Dec 2004 | $1.29 M(+4306.1%) | - | - |
| Dec 2001 | - | -$78.90 K(<-9900.0%) | $0.00(-100.0%) |
| Sept 2001 | - | $0.00(-100.0%) | $78.90 K(0.0%) |
| June 2001 | - | $78.90 K(-3857.1%) | $78.90 K(+169.3%) |
| Dec 1999 | $29.30 K(-79.1%) | -$2100.00(<-9900.0%) | $29.30 K(-6.7%) |
| Sept 1999 | - | $0.00(-100.0%) | $31.40 K(0.0%) |
| June 1999 | - | -$2900.00(-108.5%) | $31.40 K(-8.5%) |
| Mar 1999 | - | $34.30 K | $34.30 K |
| Dec 1998 | $140.00 K | - | - |
FAQ
- What is Protalix BioTherapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual CAPEX year-on-year change?
- What is Protalix BioTherapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly CAPEX year-on-year change?
- What is Protalix BioTherapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics TTM CAPEX year-on-year change?
What is Protalix BioTherapeutics annual capital expenditures?
The current annual CAPEX of PLX is $1.15 M
What is the all time high annual CAPEX for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual capital expenditures is $7.86 M
What is Protalix BioTherapeutics annual CAPEX year-on-year change?
Over the past year, PLX annual capital expenditures has changed by +$521.00 K (+82.96%)
What is Protalix BioTherapeutics quarterly capital expenditures?
The current quarterly CAPEX of PLX is $87.00 K
What is the all time high quarterly CAPEX for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly capital expenditures is $2.96 M
What is Protalix BioTherapeutics quarterly CAPEX year-on-year change?
Over the past year, PLX quarterly capital expenditures has changed by -$360.00 K (-80.54%)
What is Protalix BioTherapeutics TTM capital expenditures?
The current TTM CAPEX of PLX is $1.11 M
What is the all time high TTM CAPEX for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high TTM capital expenditures is $7.86 M
What is Protalix BioTherapeutics TTM CAPEX year-on-year change?
Over the past year, PLX TTM capital expenditures has changed by -$5000.00 (-0.45%)